Clinical Trial Update: A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

View source ↗

Summary

A study by Memorial Sloan Kettering Cancer Center aims to identify barriers to cellular therapies for people with plasma cell disorders, including multiple myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING